News
Given the advantages over its rivals, Regeneron is hopeful its bispecific antibody will become the new standard of care for ...
Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple myeloma
Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Health and Me on MSN12h
Diabetes, Obesity And Cancer: Top 10 Drugs Of 2025 Are Changing How We Fight DiseaseFrom cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...
The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by r ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback